LungLife AI (LLAI) Competitors

LungLife AI (LON:LLAI) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Is LLAI or VRCI more profitable?

Verici Dx has a net margin of -110.99% compared to LungLife AI's net margin of -15,403.45%. LungLife AI's return on equity of -56.38% beat Verici Dx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LungLife AI	-15,403.45%	-56.38%	-27.28%
Verici Dx	-110.99%	-71.67%	-26.14%

Do insiders & institutionals hold more shares of LLAI or VRCI?

42.5% of LungLife AI shares are owned by institutional investors. Comparatively, 51.9% of Verici Dx shares are owned by institutional investors. 48.4% of LungLife AI shares are owned by insiders. Comparatively, 17.1% of Verici Dx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Does the MarketBeat Community favor LLAI or VRCI?

LungLife AI and Verici Dx both received 0 outperform votes by MarketBeat users.

Company	Underperform	Outperform
LungLife AI	N/A	N/A
Verici Dx	N/A	N/A

Which has better valuation & earnings, LLAI or VRCI?

LungLife AI has higher earnings, but lower revenue than Verici Dx. Verici Dx is trading at a lower price-to-earnings ratio than LungLife AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LungLife AI	£33.87K	34.24	-£5.22M	-£12.58	-0.28
Verici Dx	£5.91M	0.64	-£6.56M	-£1.73	-0.73

Does the media prefer LLAI or VRCI?

In the previous week, LungLife AI's average media sentiment score of 0.00 equaled Verici Dx'saverage media sentiment score.

Company	Overall Sentiment
LungLife AI	Neutral
Verici Dx	Neutral

Which has more volatility and risk, LLAI or VRCI?

LungLife AI has a beta of -0.3, suggesting that its stock price is 130% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.59, suggesting that its stock price is 59% more volatile than the S&P 500.

Summary

Verici Dx beats LungLife AI on 6 of the 11 factors compared between the two stocks.